chartexchange

SYRS
SYROS PHARMACEUTICALS INC
stockOTC

EODOct 2, 2026
0.0004USD0.000%(0.00)3,490
Loading…
Loading…
Healthcare
Biotechnology
CEO
Nancy Simonian
HQ
Cambridge, MA, USA
Previous Close
$0.00
Beta
204.93
52-Week High
$0.02 2025-11-18
52-Week Low
$0.00 2026-07-27
SMA 50
$0.00
SMA 200
$0.00
Avg. Vol 10D
24,533
Avg. Vol 30D
18,108
Avg. Vol 90D
13,691
Relative Vol
0.19
26.83M
Sep 19, 2022 · 1-for-10 (reverse)
SYRS Profile

syros pharmaceuticals is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. syros has pioneered world-leading gene control research and drug discovery capabilities with a proven ability to integrate disease biology and genomic data--a proficiency that is not well represented in pharmaceutical r&d. central to the syros approach is a proprietary platform of carefully integrated assay technologies, bioinformatics, and biologic insights developed by members of syros' senior leadership. while this scientific approach has applications in many therapeutic areas, syros has demonstrated success initially in oncology, where it may help address numerous unmet medical needs.

SYRS Performance
PeriodPriceDateChangeBeta
3M0.002026-07-06+300.00%361.578
6M0.002026-04-06+100.00%429.742
1Y0.012025-10-06-92.00%204.933
2Y1.962024-10-04-99.98%—
5Y43.102021-10-05-100.00%23.050
SYRS Stock Summary

SYROS PHARMACEUTICALS INC (OTC:SYRS) stock price today is $0.00, and today's volume is 3,490. SYRS is up 0.000% today. The 30 day average volume is 18,108. SYRS market cap is $10,733 with 26.83M shares outstanding.